Connect with us

cannabis research

Pioneering cannabis chemist Dr. Raphael Mechoulam passes away at 92

Published

on


Dr. Mechoulam was the first to isolate THC in the 1960s and his research laid the foundation for medical and adult-use weed legalization.


Legendary cannabis researcher and professor Dr. Raphael Mechoulam passed away at 92. The details of his death are not public at this time.

“Raphael Mechoulam was probably the most important and influential cannabis and cannabinoids researcher of the 20th century,” said Leafly’s Nick Jikomes, PhD. “From the initial isolation of THC and CBD from cannabis to the discovery of the endogenous cannabinoids of the body, his contributions to our understanding of cannabinoid biology are second to none,” Jikomes said following the news of Mechoulam’s passing.

photo-of-raphael-mechoulam
Raphael Mechoulam isolated both CBD and delta-9 THC in the earlyt 1960s. (AP photo)

In 1964, Mechoulam published the first research ever that isolated and identified THC as the active compound in cannabis. For the next six decades, Mechoulam helped legitimize and destigmatize cannabis using scientific research. In July 2022, he published a review that charted his life’s work in cannabis.

“After a traumatic childhood in Europe during the Second World War, I found that scientific research in Israel was a pleasure beyond my expectations. Over the last 65 years, I have worked on the chemistry and pharmacology of natural products. During the last few decades, most of my research has been on plant cannabinoids… Δ9-tetrahydrocannabinol and cannabidiol, are approved drugs… For me, intellectual freedom—the ability to do research based on my own scientific interests—has been the most satisfying part of my working life. Looking back, I conclude that I have been lucky, very lucky, both personally and scientifically.”

Dr.  Mechoulam, “A Delightful Trip Along the Pathway of Cannabinoid and Endocannabinoid Chemistry and Pharmacology”

Why Dr. Raphael Mechoulam began studying cannabis

Born in Bulgaria in 1930, Mechoulam escaped the Holocaust and went on to study Biochemistry at The Hebrew University in Jerusalem.

“I was looking for natural products that have not been well evaluated and may possibly be used as drugs or for biological purposes… I was surprised to find out that morphine had been isolated from opium 150 years previously, and cocaine had been isolated from cocoa leaves 100 years previously, the active compound in cannabis had never been isolated in pure form. Some people have worked on that. But the techniques were apparently not good enough. While they knew more or less the active compounds, they never got a pure compound. And so I thought, ‘it’s a good idea to try to look at the chemistry.’”

Dr. Mechoulam

How Dr. Raphael Mechoulam changed cannabis research

Dr. Mechoulam took the first step in a long line of research that has led to legal medical and adult-use cannabis in certain states across the US and a handful of countries around the globe. Dr. Mechoulam started his research by requesting and receiving hashish from local police. “It turned out that we broke the law,” he remembered in a 2021 interview with Live Doctors. “We didn’t know that. And the police broke the law. And we should have ended up in prison.”

Cannabis ready for testing in a lab
(AdobeStock)

He eventually got the OK from the local minister of health and started legally receiving evidence from the police to use for his research.

“At that time I didn’t have a car. I get onto a bus, and people would start looking around, ‘Hey what kind of smell do we have here?’”

Dr. Mechoulam

Dr. Mechoulam and his team injected monkeys with the isolated compounds they found in cannabis and learned that THC was the only active one, since it put the monkeys to sleep. “We published that in 1964,” he said. “(But) there was very little interest in that time.” Mechoulam said he couldn’t get a grant in the US, and was told that, “No Americans used cannabis, only Mexicans.”

How Dr. Mechoulam’s work impacted legalization in the US

DEA-lawsuit-medical-marijuana
A new lawsuit would force the DEA to reconsider the criteria set in 1992 to determine the ‘accepted medical use’ of cannabis. (AdobeStock)

The American government’s interest in cannabis changed a year or two later, when Dr. Mechoulam said a US politician’s son came rushing to him for guidance. They wanted to know if their son’s brain was at risk from smoking pot.

“They came over and at that time we had isolated the first pure batch of THC,” Prof. Mechoulam said. “They took it, they smuggled it into the US. They didn’t have a permit.”

Dr. Mechoulam

According to Dr. Mechoulam, “Some of the research that was done at the beginning in the US was done with the material that we had.” Decades later, US researchers would identify the human body’s endocannabinoid receptors by building on Dr. Mechoulam’s work. Medical and recreational cannabis laws would soon follow, thanks in large part to this trailblazer of cannabis culture.



Source link

Continue Reading

anxiety

CBD vs. THC for Anxiety Relief: New Study Finds the Answer

Published

on

By


A groundbreaking study conducted by the University of Colorado Boulder reveals that strains of cannabis high in cannabidiol (CBD) and low in tetrahydrocannabinol (THC) are most effective at alleviating anxiety. This research, the first to examine the acute and extended effects of legal market cannabis products on anxiety symptoms, underscores the therapeutic potential of CBD, offering a safer alternative to THC-dominant strains and prescription medications for anxiety relief.

Cannabis has long been a subject of debate due to its varied effects on different individuals, with some experiencing relaxation and others facing heightened paranoia and anxiety. This study provides scientific backing to the anecdotal evidence, pinpointing CBD as the key compound for anxiety relief without the adverse effects associated with THC.

The research team embarked on a first-of-its-kind experiment involving 300 participants with anxiety, assessing their responses to different strains of cannabis with varying levels of THC and CBD. The study categorized the cannabis strains into three groups: THC-dominant, equal parts THC and CBD, and CBD-dominant, alongside a control group with no cannabis use.

Over the course of four weeks, participants reported their experiences, with those using CBD-dominant strains experiencing significant reductions in tension and anxiety without the impairment or paranoia linked to higher THC levels. Notably, even the THC-containing strains did not exacerbate anxiety over the long term, suggesting that THC’s anti-anxiety effects might still be beneficial compared to abstaining from cannabis use altogether.

This research, published in Cannabis and Cannabinoid Research, offers compelling evidence of CBD’s role in anxiety management, potentially guiding legal prescriptions and product development in countries that have embraced medical cannabis.

Why It Matters: The findings highlight the importance of understanding cannabis’s chemical composition for therapeutic use, particularly for anxiety treatment. By distinguishing the effects of CBD from THC, this study paves the way for safer, more effective anxiety treatments that harness the benefits of cannabis without the risk of exacerbating anxiety symptoms.

Potential Implications: This study could significantly impact the medical cannabis industry, influencing the development of CBD-dominant products for anxiety relief. It may also inform regulatory policies and consumer choices, encouraging a shift towards strains and products that provide the therapeutic benefits of cannabis without the negative side effects associated with high THC levels.

Source: ScienceAlert



Source link

Continue Reading

business

Medical Cannabis Market to Reach USD 60.04 Billion by 2030

Published

on

By


Summary: The global medical cannabis market is expected to grow significantly, reaching an estimated value of USD 60.04 billion by 2030, driven by increased legalization and growing awareness of its therapeutic benefits.

The Booming Future of Medical Cannabis: Market to Reach USD 60.04 Billion By 2030

According to SkyQuest, the medical cannabis industry is poised for substantial growth in the coming years, with projections indicating that the market could reach a staggering USD 60.04 billion by 2030. This growth is attributed to the increasing legalization of cannabis for medical purposes across various countries and the growing recognition of its therapeutic benefits.

The market’s expansion is fueled by extensive research and clinical trials demonstrating the efficacy of medical cannabis in treating a range of conditions, including chronic pain, epilepsy, and multiple sclerosis. This has led to a broader acceptance of cannabis in the medical community and among patients seeking alternative treatments.

The rise in the number of countries legalizing medical cannabis is a significant factor contributing to market growth. As more governments recognize the medical value of cannabis and implement regulatory frameworks, the market is expected to witness increased demand and investment.

The medical cannabis market is also benefiting from advancements in cultivation techniques and product development. Innovations in extraction methods and the development of various cannabis-based products, such as oils, tinctures, and edibles, are making it more accessible and appealing to a wider patient base.

However, the market faces challenges, including regulatory hurdles and the stigma associated with cannabis use. Despite these challenges, the industry’s potential for growth remains high, driven by ongoing research, patient advocacy, and a shift in public perception towards cannabis.

As the medical cannabis market continues to evolve, it presents significant opportunities for investors, healthcare providers, and patients. The industry’s growth is expected to contribute to the development of new treatments and improve the quality of life for patients worldwide.

Why It Matters: The projected growth of the medical cannabis market to USD 60.04 billion by 2030 highlights the increasing acceptance and demand for cannabis-based therapies. This growth signifies a major shift in healthcare, offering new treatment options for patients and opportunities for innovation in the medical field.

Potential Implications: The expansion of the medical cannabis market could lead to more widespread use of cannabis-based treatments, influencing healthcare practices and policies. It may also drive further research into the medicinal properties of cannabis, potentially leading to new discoveries and treatments for various medical conditions.

Source: 420 Intel


Subscribe to our weekly newsletter:

We hope you enjoyed this news update. Check back with us daily to see what’s going on in the world of cannabis and psychedelics. And make sure to subscribe to our weekly newsletter, the Cannadelics Sunday Edition with a the best stories of the week:

.

.

AI Disclaimer: This news update was created using a AI tools. PsychePen is an AI author who is constantly improving. We appreciate your kindness and understanding as PsychePen continues to learn and develop. Please note that the provided information is derived from various sources and should not be considered as legal, financial, or medical advice.



Source link

Continue Reading

American Legion

Veterans Show Strong Support for Medical Cannabis Legalization

Published

on

By


Summary: A recent survey indicates that a significant majority of U.S. military veterans support the expansion of medical cannabis access. The survey, conducted by the American Legion, highlights the growing acceptance of medical marijuana among veterans, especially for treating conditions like chronic pain and PTSD.

Military Veterans Rally for Expanded Access to Medical Cannabis

The American Legion, a prominent U.S. veterans organization, recently conducted a survey that reveals a substantial majority of military veterans favor the expansion of medical cannabis access. This survey, involving thousands of veteran respondents, underscores the shifting attitudes towards medical marijuana within the veteran community.

The survey’s findings indicate that veterans are increasingly supportive of medical cannabis as a viable treatment option for various conditions, including chronic pain and post-traumatic stress disorder (PTSD). Many respondents expressed their belief that medical marijuana offers a safer and more effective alternative to traditional prescription medications, particularly opioids.

The results showed that over 80% of surveyed veterans support the federal legalization of medical cannabis, and a similar percentage advocate for research into the medical benefits of marijuana. Additionally, a significant number of respondents reported using cannabis to alleviate symptoms associated with their military service, including chronic pain, anxiety, and PTSD.

The survey also highlighted the challenges veterans face in accessing medical cannabis, with many living in states where it remains illegal or heavily restricted. The respondents called for policy changes at both the federal and state levels to improve access to medical marijuana for veterans.

The American Legion’s survey is part of its ongoing efforts to advocate for veteran health and wellbeing. The organization has been vocal in urging the federal government to reclassify cannabis to facilitate more comprehensive research and to recognize its potential therapeutic benefits for veterans.

Why It Matters: This survey is significant as it reflects the growing acceptance and demand for medical cannabis among U.S. military veterans. It underscores the potential of medical marijuana in addressing the unique health challenges faced by veterans, particularly those related to their service.

Potential Implications: The survey’s findings could influence policymakers and healthcare providers to consider revising regulations and expanding access to medical cannabis for veterans. It may also encourage further research into the efficacy and safety of cannabis in treating conditions prevalent among the veteran population.

Source: NORML


Subscribe to our weekly newsletter:

We hope you enjoyed this news update. Check back with us daily to see what’s going on in the world of cannabis and psychedelics. And make sure to subscribe to our weekly newsletter, the Cannadelics Sunday Edition with a the best stories of the week:

.

.

AI Disclaimer: This news update was created using a AI tools. PsychePen is an AI author who is constantly improving. We appreciate your kindness and understanding as PsychePen continues to learn and develop. Please note that the provided information is derived from various sources and should not be considered as legal, financial, or medical advice.



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media